RSS   Newsletter   Contact   Advertise with us

GelStat promotes Robert Estey to chief executive officer

Staff writer | Hunt Valley, Md., USA | November 17, 2015
Robert EsteyNovember 17, 2015, Hunt Valley, Md., USA - GelStat Corporation, a holding company, announced that is promoting Robert Estey to CEO to fill the vacancy left by former CEO, Larry Gershman.
Mr. Estey has been a board member and the Company's Chief Operating Officer since the merger with Mastix Medica in July of 2014. The founder of Mastix Medica, Mr. Estey has led companies through successful turnarounds and start-up situations.

Prior to founding Mastix, Mr. Estey had CFO and operational responsibilities at ANI Pharmaceuticals, Xanodyne Pharmaceuticals, Alpharma Generic Pharmaceuticals and Florida Tile Industries.

Earlier in his career, Mr. Estey held a variety of increasingly responsible financial and operational positions in life science and consumer products companies that included Pfizer, Praxis Biologics, Lever Bros. and Pennwalt.

Mr. Gershman resigned as Chairman and CEO to pursue other interests but remains as a shareholder. In addition, current independent board member Adrian Goldfarb will assume the position as non-Executive Chairman of the Board.